From model to man: Understanding Tregs' dual role in MASLD

Diet-induced steatohepatitis can develop without adaptive immunity, yet IL-17A-expressing Foxp3<sup>+</sup> T regulatory cells (Tregs) and CD8<sup>+</sup> T cells markedly amplify hepatocellular injury and fibrosis. By separating initiating (macrophage-driven) from amplifying (adaptive) immune signals, our study refines current pathogenic models and provides hepatologists and immunologists with stage-specific therapeutic targets. For clinicians and trial designers, the data indicate that stabilizing Tregs or selectively dampening pro-inflammatory T-cell subsets could complement metabolic interventions in metabolic dysfunction-associated steatotic liver disease/steatohepatitis, whereas indiscriminate Treg expansion might be counter-productive. Because the conclusions are drawn from a murine model, translation to humans will require validation in patient-derived tissues and non-invasive immune biomarkers.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-10-09
DOI
https://doi.org/10.1016/j.jhepr.2025.101619
Citations
2
Primary Topic
Genetic Syndromes and Imprinting
Type
article
Field-Weighted Citation Impact
3.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From model to man: Understanding Tregs' dual role in MASLD

Michael P. Manns, Ana Clara Marques Davalos‐Misslitz, Janine Dywicki, Christian Koenecke et al.
2 citations
JHEP Reports
Genetic Syndromes and Imprinting
3.63
article

From model to man: Understanding Tregs' dual role in MASLD

Michael P. Manns, Ana Clara Marques Davalos‐Misslitz, Janine Dywicki, Christian Koenecke, Richard Taubert, Elmar Jaeckel, Christine S. Falk, Katharina Luise Hupa‐Breier, Benjamin Heidrich, Jérôme Schlué, Maren Lieber, Celina M. Hendriks, Laura Elisa Buitrago‐Molina, Freya Wellhöner, Matthias Blüher, Fatih Noyan, Heiner H. Wedemeyer, Matthias Hardtke‐Wolenski, Anna Baumann, Heike Bantel
article en
2 citations

Abstract

Diet-induced steatohepatitis can develop without adaptive immunity, yet IL-17A-expressing Foxp3<sup>+</sup> T regulatory cells (Tregs) and CD8<sup>+</sup> T cells markedly amplify hepatocellular injury and fibrosis. By separating initiating (macrophage-driven) from amplifying (adaptive) immune signals, our study refines current pathogenic models and provides hepatologists and immunologists with stage-specific therapeutic targets. For clinicians and trial designers, the data indicate that stabilizing Tregs or selectively dampening pro-inflammatory T-cell subsets could complement metabolic interventions in metabolic dysfunction-associated steatotic liver disease/steatohepatitis, whereas indiscriminate Treg expansion might be counter-productive. Because the conclusions are drawn from a murine model, translation to humans will require validation in patient-derived tissues and non-invasive immune biomarkers.

JHEP ReportsVol. 7(12)
University Health Network (CA), Leipzig University of Applied Sciences (DE), Medizinische Hochschule Hannover (DE), Essen University Hospital (DE), University Hospital Leipzig (DE), IFB Adiposity Diseases (DE), University of Duisburg-Essen (DE), Leipzig University (DE)
Openalex Percentile: Top 6%
Genetic Syndromes and Imprinting
3.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.